MedTrace Logo

Mitralign Percutaneous Annuloplasty System for Chronic Functional Mitral Valve Regurgitation

NCT01740583 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-10-17

No results posted yet for this study

Summary

The purpose of this study is to test the safety and device performance of the Mitralign system ("MPAS") to treat functional mitral valve regurgitation.

Conditions

  • Mitral Valve Regurgitation

Interventions

DEVICE

percutaneous annuloplasty

plication of the mitral valve annulus

Sponsors & Collaborators

  • Mitralign, Inc.

    lead INDUSTRY

Principal Investigators

  • Adrian Ebner, M.D. · Sanatorio Italiano (The Italian Hospital)

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2017-01-31
Completion
2017-11-30

Countries

  • Colombia
  • France
  • Paraguay
  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01740583 on ClinicalTrials.gov